Kymera Therapeutics Inc

The current institutional shareholding score of Kymera Therapeutics Inc is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 117.53%, representing a quarter-over-quarter increase of 8.46%. The largest institutional shareholder is ETHSX, holding a total of 35.86K shares, representing 0.04% of shares outstanding, with 0.00% increase in holdings.